e-learning
resources
Glasgow 2004
Saturday 04.09.2004
PG13 - Lung diffusion measurements in diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Measurement of lung diffusion in cardiovascular disease
M. Guazzi (Milan, Italy)
Source:
Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases
Session:
PG13 - Lung diffusion measurements in diseases
Session type:
Postgraduate Course
Number:
77
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Guazzi (Milan, Italy). Measurement of lung diffusion in cardiovascular disease. Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
ERS statement on chronic thromboembolic pulmonary hypertension
COVID-19 and the pulmonary circulation
Related content which might interest you:
Measurement of lung diffusion in obstructive lung disease
Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases
Year: 2004
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020
Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Prediction of chronic lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 139s
Year: 2003
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001
Relationship between lung function disorders and condition of cardiovascular system in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003
Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Investigation of relationships between inflammation and brain disease in COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
Risk assessment in severe pulmonary hypertension due to interstitial lung disease
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Monitoring of CF lung disease
Source: ERS course 2015
Year: 2015
Relationship between respiratory exchange ratio and pulmonary function in patients with obstructive lung disease
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021
Measurement of diffusion in pulmonary vascular disorders
Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases
Year: 2004
Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020
Quantitative CT for the assessment of disease severity in interstitial lung disease
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
Murine models of cardiovascular damage in lung diseases
Source: Eur Respir Monogr 2020; 88: 31-46
Year: 2020
Determination of pulmonary hypertension degree in patients with interstitial lung diseases
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept